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Due to the constant increase of peripheral disease the physician is always
more frequently obliged to diagnose and treat disorders of peripheral blood
circulation in the limbs. In a mixed group of out-patients having disorders of
the peripheral blood circulation 15 % of the diseases concern the arterial vessels;
70 % of the affections are purely venous, while 10 % concern the arterial as
well as the venous vessels (Kappert). The following distinctions fall under the
general notion of peripheral disease in its widest sense:
I Affections of Arteries and Arterioles
1. Organic forms (Figs. 1 and 2)
a) Arterial occlusive diseases: Arteriosclerosis obliterans, arterial embolism
arterial thrombosis, thromboangiitis obliterans, arteritis of different origins,
diabetic angiopathy and gangrene, aortic arch syndrome, disorders due to lesions,
disorders due to cold or humidity
b) Non-occlusive organic arteriopathies: Arterial aneurysm, arteriovenous
fistula
2. Functional Forms
a) With tendency towards vasoconstriction: Digitus mortuus Raynaud's
disease and Raynaud's phenomenon, acrocyanosis, arterial pseudoembolism,
crural erythrocyanosis, lividity, neurovascular shoulder-girdle syndrome, brachi-
algia statica paresthetica
b) With tendency towards vasodilation: Erythromelalgia
I I Venopathies: Varicosis, thrombophlebitis and phlebothrombosis, phleg-
masia cerulea dolens, migrating phlebitis, postphlebitic and post-thrombotic
syndromes, venous varicose ulcer
I I I Capillary Disease: Vascular purpura
IV Disease of the Lymphatic Vessels: Lymphangiitis, lymphedema
V Tumors and Dysplasia of the Blood Vessels: Hemangioma, etc.,
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benign as well as malignant forms.
Ulcerative and/or necrotic lesions of a series of the above-mentioned forms
of peripheral circulatory disease are particularly crucial. These may be due to
disorders of the arterial as well as the venous peripheral blood circulation, and
are the manifestations of the metabolic catastrophy taking place in the dependant
tissues.
There are countless methods for their treatment, which indicates that the
therappeutic results are not satisfactory.
In the last few years numerous well-known authors have reported on the
use of a deproteinized calf-blood extract in the treatment of disorders of the
peripheral blood circulation, more particularly of the ulcerations that accompany
them.
This deproteinized calf-blood extract is marketed under the brand name
Solcoseryl. The biological action of Solcoseryl consists in improving the utiliza-
tion of oxygen and thereby increasing the metabolism of animal and vegetable
tissues about three-fold in relation to the controlled measurement in Warburg's
microrespirometer (JAEGER, SZIRMAI).
Investigations made by JAEGER and MITTENZWEI on isolated liver mitochon-
dria revealed that the oxygen consumption of tissues incubated with Solcoseryl
or of mitochondria treated with So1coseryl is higher than that of the controls,
it being essential that the PIO quotient remains unchanged, i. e. that the increase
in respiration runs parallel with an increase in phosphates rich in energy. This
is not a decoupling of oxidative phosphorylation, nor an isolated substrate
effect, as that which can be observed when certain substrates are added. The
increase in respiration inside the tissues, which the above-mentioned authors
observed, lies markedly above the values that can be obtained with the known
substrates.
The results of numerous animal experiments and clinical trials in hypoxydo-
tic conditions correspond with those obtained by the above-mentioned authors
showing that proresses in which So1coseryl intervenes are favoured by a high
requirement of energy (ion exchange, healing of wounds, regeneration of tissues)
and that the tolerance of noxae and oxygen deficiency is considerably increased.
Thus WICKINGEN was able to prove on a total of sixty-six swines with sacrifice
of identical form and size that Solcoseryl significantly accelerated the healing
process in comparison to that of the untreated controls and without producing
any retraction of the borders of the wounds. This replacement of substance in
cases of fairly deep loss of tissue was also observed by other authors (COUCOURDE
and SCHIFINO). Granulation and epithelialization of the wounds are accelerated,
retraction of the borders is insignificant, and scarcely any cicatricial contraction
is noted. Heavily secreting and suppurating wounds clean rapidly, and blood
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circulation is improved both.in the affected area and in the trophically disturbed
surrounding area. Granules appear in the depth of the wound and they con-
verge forming a granular mass progressing from the center towards the borders,
thus making up for the loss of substance. Strips of epithelium project from the
borders towards the center. The epithelialization occurs along with and ahead
of the replacement of the substance. In no instance did there appear any wild
over-growing granulation. It is most impressive that improvement takes place
after only a few days' treatment and subjective discomforts such as pain, pares-
thesia, or cold limbs gradually disappear.
Complete healing takes comparatively little time, if one considers the usual
duration and habitual resistance to therapeutics of such lesions. The vasculari-
zation of the skin covering these wounds is usually good, the skin is soft and
pink with smooth elastic scars. Practically no cicatricial hypertrophy has ever
been observed. It is absolutely essential to persist in the treatment with Solce-
seryl even if the results do not seem encouraging at first.
In cases of gangrene in which amputation is contemplated, an intensive
treatment with Solcoseryl can frequently ensure a partial amputation only.
Demarcation of the necroses allows one to distinguish between irreversibly lost
tissue and repairable lesions. In diabetes it is, of course, necessary to control
the basic illness.
The following general1ines should be taken into account for the treatment
of all severe cases: 1. In disorders of arterial blood circulation intraarterial
infusions of 1 to 5 ampules of Solcoseryl with glucose added (for diabetics with
sorbitol) should be given daily. 2. In disorders of the venous blood circulation
treatment should consist of 1 to 2 ampules daily in intramuscular or intravenous
injections. 3. In disorders of arterial and venous blood circulation the physician
should choose the method which proves to be most successful; but in any case
it is advisable to combine parenteral therapy with topical applications of 5%
Solcoseryl ointment or 20% Solcoseryl jelly. It is recommended to cover heavily
secreting, suppurating and necrotic ulcers daily with a layer of Solcoseryl jelly
of the thickness of a knife blade, until the ulcer is clean, necroses have fallen
off, and the secretion has subsided. The treatment should be continued with
ointment applied to the wound on cloth until healing is complete. At the same
time the parenteral treatment should be reduced to an appropriate maintenance
dose of 1 to 2 ampules threce times a week.
In extremely severe cases, particularly after amputations or in very ex-
tended and deep ulcers with scarce healing tendency, daily spraying of the
lesions with 1 to 2 ampules of Solcoseryl or local injections of Solcoseryl into
the border of the lesion or in the healthy area immc:diately surrounding the same,
have proved useful.
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In the above described manner numerous clinicians have obtained healing
of more than 8096 of trophic lesions which had resisted treatment for over 20
years. These lesions were due to disorders of blood circulation of the most
varied origin, even of mal perforans leprosum (SZIRMAI, MANCOSU, UGO, ERBA
and CASATI, GORI·SAVELLlNI and MELONI, ERBA, KAPPERT, POHL, AZAM,
STRATMANN, MEHREz, HAMMAN and SHAFIK, MEYTHALER, ELL and DERLATZ,
WOLFRAM, WySS and BASTI).
OWN OBSERVATIONS
I first began using Solcoseryl in 1955 and 1956 in CI Arpad" Hospital in
Budapest, and first reported on the results, especially for the treatment of crural
ulcers, in 1959 (Table 1, 1955--1966). As I had used most known methods in
Table 1 Own Observations (1955-1966)
Diagnosis
I
Number
I-gOOd
Results
of cases middle no change
Affections of arteries and arterioles
1. Organic forms
a) Arterial occlusive disease 150 100 30 20 (sevre ecases)
b) Non occlusive organic arteriopathies 190 160 28 2
2. Functional forms
a) with tendency towards vasoconstriction 96 90 5 1
b) with tendency towards vasodilatation 52 38 10 2
II Venopathies 320 270 36 14
III Capillary disease 146 120 20 6
IV Disease of the lymphatic vessels 46 38 5 3
V Tumours and dysplasia of the blood vessels 34 30 2 2
VI Radiation reaction 140 128 4 8
VII Ulcus ventriculi et duodeni 130 97 20 13
this field for about eighteen years, I can affirm that I have obtained very satis-
factory results with Solcoseryl in a considerable number of cases. From the
outset I recorded blood circulation and various other factors in all cases treated
with Solcoseryl not only with the methods known at the time but also with an
as yet little known apparatus which I have developed, viz. the myotonometer
(Fig. I-a, b), the angiomyograph, and the mechanical myograph. Myappara-
tus, in particular the angiomyograph, records capillary functions, through the
modifications of muscular volume, that the oscillometer does not register. Thus
it is possible to control with the angiomyograph acute and chronic activity tests
of medicaments on arteries, veins, muscles. tissues, edema, innervations,
eet.
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Fig. 1-a The angiomyogram of a crural ulcer which was treated with Solcoseryl. X: leg, Y
: thigh, A: passive movement, B: active movement.
Fig. 1-b Is an angiomyogram of the same patient. The amplitude of this angiomyogram is much
wider, which shows that improvement of the ulcer was accompanied by the improvement
of blood circulstion.
Fig. 2-1 This electron micrograph of a human meningeal arteriole from a patient with hyper-
tension shows a thickened basement membrane (hyalinosis of light microscopy) X6,000
Fig. 2-2 This electron micrograph shows the intimal coat with an atheromatous haemorrhagic
plaque in an artery of the human brain. Seven red blood cells lie in Cl cleft within the
thickened basement membrane. A fibrinous clot surrounds the red blood cells. X 6,000
I frequently observed that pain subsided when the treatment with Solcoseryl
was successfnl. This can be explained by my "oxygen insufficiency theory"
(=OIT) according to which every pain is due to a state of hypoxemia or ano-
xemia, in which cell combustion takes place only in part, and the half-burnt
cellulose irritates the nerve endings. This is a chemical process, like that taking
place in an oven, in which insufficient ventilation causes lack of oxygen supply.
The so-called oxygen insufficiency can be favourably influenced by an improved
blood circulation, i. e. an improved oxygen supply. (My so-called GTopc-theory
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= general therapy of improved oxygenation of the peripheral circulation).
Thereby every pathological condition can be favourably influenced and every
pain (except in cancer) calmed without anesthetics.
From the above it can be inferred that every pain and every pathological
condition in connection with disorders of the blood circulation, which indirectly
affect various organs, can be favourably influenced and possibly healed with
Solcoseryl (Table 1).
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